Tigatuzumab (CS-1008)
Revision as of 22:44, 26 November 2014 by Jwarner (talk | contribs) (Created page with "=Mechanism of action= Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) Category:Drug index [[Categ...")
Mechanism of action
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2)